Initial Heparin Dose Modification
Phase 3Small molecule
Initial Heparin Dose Modification is one of 7 small molecule programs targeting Heart. It is currently in Phase 3.
1
Indications
1
Total Trials
1
Active Trials
6
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
7 competitors in Heart
#DrugCompanyPhaseTrials
1Ephedrine Sulfate
DDr. Reddys Laboratories, SA
Approved
Avelox
BayerPhase 1
Maridebart Cafraglutide
AmgenPhase 1
Initial Heparin Dose Modification
IInova Health Care Services
Phase 3
Sudafed
KKenvue Brands
Preclinical
Glucagon Like Peptide-1
UUniversity Hospital, Gentofte, Copenhagen
Preclinical
Room Air
MMassachusetts General Hospital
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Phase 3[1]
- Company
- IInova Health Care Services